Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes.

Cohen R, le Roux CW, Papamargaritis D, Salles JE, Petry T, Correa JL, Pournaras DJ, Galvao Neto M, Martins B, Sakai P, Schiavon CA, Sorli C.

Diabet Med. 2013 Dec;30(12):1482-6. doi: 10.1111/dme.12268. Epub 2013 Jul 19.

PMID:
23802863
2.

Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.

de Jonge C, Rensen SS, Verdam FJ, Vincent RP, Bloom SR, Buurman WA, le Roux CW, Schaper NC, Bouvy ND, Greve JW.

Obes Surg. 2013 Sep;23(9):1354-60. doi: 10.1007/s11695-013-0921-3.

PMID:
23526068
3.

Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes.

Klein S, Fabbrini E, Patterson BW, Polonsky KS, Schiavon CA, Correa JL, Salles JE, Wajchenberg BL, Cohen R.

Obesity (Silver Spring). 2012 Jun;20(6):1266-72. doi: 10.1038/oby.2011.377. Epub 2012 Jan 19.

4.

Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.

de Moura EG, Martins BC, Lopes GS, Orso IR, de Oliveira SL, Galvão Neto MP, Santo MA, Sakai P, Ramos AC, Garrido Júnior AB, Mancini MC, Halpern A, Cecconello I.

Diabetes Technol Ther. 2012 Feb;14(2):183-9. doi: 10.1089/dia.2011.0152. Epub 2011 Sep 20.

PMID:
21932999
5.

Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.

Lee WJ, Chong K, Chen CY, Chen SC, Lee YC, Ser KH, Chuang LM.

Obes Surg. 2011 Jul;21(7):889-95. doi: 10.1007/s11695-011-0401-6.

PMID:
21499957
7.

The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.

Kim MK, Lee HC, Lee SH, Kwon HS, Baek KH, Kim EK, Lee KW, Song KH.

Diabetes Metab Res Rev. 2012 Jul;28(5):439-46. doi: 10.1002/dmrr.2297. Epub 2012 Mar 8.

PMID:
22407971
8.

Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.

Lee WJ, Ser KH, Chong K, Lee YC, Chen SC, Tsou JJ, Chen JC, Chen CM.

Surgery. 2010 May;147(5):664-9. doi: 10.1016/j.surg.2009.10.059. Epub 2009 Dec 11.

PMID:
20004451
9.

Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.

Stratmann B, Krepak Y, Schiffer E, Jarick I, Hauber M, Lee-Barkey YH, Fischer M, Tschoepe D.

Horm Metab Res. 2016 Sep;48(10):630-637. Epub 2016 Sep 2.

PMID:
27589345
10.

Defining and predicting complete remission of type 2 diabetes: a short-term efficacy study of open gastric bypass.

Yan H, Tang L, Chen T, Kral JG, Jiang L, Li Y, Hu R, Cui J, Li S, Tian F.

Obes Facts. 2013;6(2):176-84. doi: 10.1159/000351018. Epub 2013 Apr 12.

11.

Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus.

Kaválková P, Mráz M, Trachta P, Kloučková J, Cinkajzlová A, Lacinová Z, Haluzíková D, Beneš M, Vlasáková Z, Burda V, Novák D, Petr T, Vítek L, Pelikánová T, Haluzík M.

J Endocrinol. 2016 Oct;231(1):11-22. doi: 10.1530/JOE-16-0206. Epub 2016 Jul 29.

PMID:
27474690
12.

Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study.

Geloneze B, Geloneze SR, Chaim E, Hirsch FF, Felici AC, Lambert G, Tambascia MA, Pareja JC.

Ann Surg. 2012 Jul;256(1):72-8. doi: 10.1097/SLA.0b013e3182592c62.

PMID:
22664560
13.

Effect of Duodenal-Jejunal Bypass Surgery on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial.

Petry TZ, Fabbrini E, Otoch JP, Carmona MA, Caravatto PP, Salles JE, Sarian T, Correa JL, Schiavon CA, Patterson BW, Cohen R, Klein S.

Obesity (Silver Spring). 2015 Oct;23(10):1973-9. doi: 10.1002/oby.21190.

14.

[Effect of blood glucose control after small intestine exclusion surgery in Goto-Kakizaki rat with type 2 diabetes mellitus].

Wang Y, Zhang ZZ, Wang L, Deng ZZ, Jiao YB, Zou ZD.

Zhonghua Yi Xue Za Zhi. 2009 Nov 3;89(40):2858-61. Chinese.

PMID:
20137669
15.

Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.

Aarts EO, Janssen J, Janssen IM, Berends FJ, Telting D, de Boer H.

Obes Surg. 2013 Jul;23(7):867-73. doi: 10.1007/s11695-013-0872-8.

PMID:
23475775
16.

Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.

Cohen R, Caravatto PP, Correa JL, Noujaim P, Petry TZ, Salles JE, Schiavon CA.

Surg Obes Relat Dis. 2012 Jul-Aug;8(4):375-80. doi: 10.1016/j.soard.2012.01.017. Epub 2012 Feb 2.

PMID:
22410638
17.

Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass.

Han H, Wang L, Du H, Jiang J, Hu C, Zhang G, Liu S, Zhang X, Liu T, Hu S.

Obes Surg. 2015 Oct;25(10):1802-9. doi: 10.1007/s11695-015-1633-7.

PMID:
25726319
18.

Duodenal-jejunal bypass and jejunectomy improve insulin sensitivity in Goto-Kakizaki diabetic rats without changes in incretins or insulin secretion.

Salinari S, le Roux CW, Bertuzzi A, Rubino F, Mingrone G.

Diabetes. 2014 Mar;63(3):1069-78. doi: 10.2337/db13-0856. Epub 2013 Nov 15.

19.

Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model.

Hu C, Zhang G, Sun D, Han H, Hu S.

Obes Surg. 2013 Sep;23(9):1436-44. doi: 10.1007/s11695-013-0976-1.

PMID:
23636998
20.

Effects of gastric bypass on type 2 diabetes in patients with BMI 30 to 35.

Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Briatore L, Andraghetti G, Catalano M, Cordera R.

Obes Surg. 2014 Jul;24(7):1036-43. doi: 10.1007/s11695-014-1206-1.

PMID:
24647849

Supplemental Content

Support Center